Immatics NV (IMTX)
8.50
-0.07
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
8.50
0.00 (0.00%)
After-Hours: 20:00
Immatics Enterprise Value: 314.32M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 314.32M |
| November 12, 2024 | 305.04M |
| November 11, 2024 | 362.78M |
| November 08, 2024 | 384.44M |
| November 07, 2024 | 384.44M |
| November 06, 2024 | 378.25M |
| November 05, 2024 | 395.78M |
| November 04, 2024 | 394.75M |
| November 01, 2024 | 392.68M |
| October 31, 2024 | 368.97M |
| October 30, 2024 | 382.37M |
| October 29, 2024 | 395.78M |
| October 28, 2024 | 387.53M |
| October 25, 2024 | 385.47M |
| October 24, 2024 | 413.31M |
| October 23, 2024 | 395.78M |
| October 22, 2024 | 414.34M |
| October 21, 2024 | 422.59M |
| October 18, 2024 | 449.39M |
| October 17, 2024 | 415.37M |
| October 16, 2024 | 405.06M |
| October 15, 2024 | 409.18M |
| October 14, 2024 | 389.08M |
| October 11, 2024 | 393.72M |
| October 10, 2024 | 394.23M |
| Date | Value |
|---|---|
| October 09, 2024 | 572.09M |
| October 08, 2024 | 561.78M |
| October 07, 2024 | 557.65M |
| October 04, 2024 | 550.44M |
| October 03, 2024 | 497.85M |
| October 02, 2024 | 515.38M |
| October 01, 2024 | 586.52M |
| September 30, 2024 | 607.14M |
| September 27, 2024 | 640.14M |
| September 26, 2024 | 640.14M |
| September 25, 2024 | 647.36M |
| September 24, 2024 | 634.98M |
| September 23, 2024 | 644.26M |
| September 20, 2024 | 676.23M |
| September 19, 2024 | 684.47M |
| September 18, 2024 | 687.57M |
| September 17, 2024 | 685.51M |
| September 16, 2024 | 743.24M |
| September 13, 2024 | 738.09M |
| September 12, 2024 | 715.41M |
| September 11, 2024 | 636.01M |
| September 10, 2024 | 660.76M |
| September 09, 2024 | 686.54M |
| September 06, 2024 | 640.14M |
| September 05, 2024 | 609.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
94.25M
Minimum
Apr 12 2023
861.84M
Maximum
Mar 01 2024
464.48M
Average
477.03M
Median
Aug 30 2022
Enterprise Value Benchmarks
| Affimed NV | 30.82M |
| InflaRx NV | 20.31M |
| BioNTech SE | 8.336B |
| CureVac NV | 394.66M |
| ATAI Life Sciences NV | 157.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.41M |
| Revenue (Quarterly) | 20.19M |
| Total Expenses (Quarterly) | 48.80M |
| EPS Diluted (Quarterly) | -0.183 |
| Profit Margin (Quarterly) | -96.09% |
| Earnings Yield | -10.56% |
| Normalized Earnings Yield | -11.41 |